Skip to main content
Equibles

Nancy Freda-Smith

Board Member

Tempest Therapeutics, Inc. (TPST)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Nancy Freda-Smith

Nancy Freda-Smith is recorded as Board Member at Tempest Therapeutics, Inc. (TPST). Tempest Therapeutics, Inc. reported in an 8-K filed September 28, 2026 that Nancy Freda-Smith was appointed Board of Directors, effective September 23, 2026. Tempest Therapeutics, Inc. reported in an 8-K filed September 28, 2026 that Nancy Freda-Smith was appointed Class III director, effective September 22, 2026.

“Tempest Therapeutics, Inc. (Nasdaq: TPST) ("Tempest"), a clinical-stage biotechnology company developing in vivo CAR-T therapies designed to reset dysfunctional immunity in cancer and autoimmune disease, today announced that Nancy Freda-Smith has been appointed to its board of directors and will serve as Chair of the Audit Committee.”
Tempest Therapeutics, Inc. Form 8-K, filed September 28, 2026 · Read the filing
“Effective September 22, 2026, the Board appointed Ms. Nancy Freda-Smith as Class III director to fill a vacancy on the Board.”
Tempest Therapeutics, Inc. Form 8-K, filed September 28, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Tempest Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.